PGC-1alpha as modifier of onset age in Huntington disease

Molecular Neurodegeneration

Volumn 4, Issue 1, 2009, Pages

  Taherzadeh Fard, Elahe ^a   Saft, Carsten ^b   Andrich, Jürgen ^b   Wieczorek, Stefan ^a   Arning, Larissa ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 60849109499     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-4-10     Document Type: Article

References (22)

1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group, Cell 1993 72 971 983 10.1016/0092-8674(93)90585-E 8458085
2. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. RG Snell JC MacMillan JP Cheadle I Fenton LP Lazarou P Davies ME MacDonald JF Gusella PS Harper DJ Shaw, Nat Genet 1993 4 393 397 10.1038/ng0893-393 8401588
3. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. SE Andrew YP Goldberg B Kremer H Telenius J Theilmann S Adam E Starr F Squitieri B Lin MA Kalchman, Nat Genet 1993 4 398 403 10.1038/ng0893-398 8401589
4. Trinucleotide repeat length instability and age of onset in Huntington's disease. M Duyao C Ambrose R Myers A Novelletto F Persichetti M Frontali S Folstein C Ross M Franz M Abbott, Nat Genet 1993 4 387 392 10.1038/ng0893-387 8401587
5. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. P Kehoe M Krawczak PS Harper MJ Owen AL Jones, J Med Genet 1999 36 108 111 10051007
6. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. The U.S.-Venezuela Collaborative Research Project and Wexler NS, Proc Natl Acad Sci USA 2004 101 3498 3503 14993615 10.1073/pnas.0308679101
7. The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease. S Metzger P Bauer J Tomiuk F Laccone S Didonato C Gellera P Soliveri HW Lange H Weirich-Schwaiger GK Wenning, Neurogenetics 2006 7 27 30 10.1007/s10048-005-0023-z 16369839
8. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner. L Arning C Saft S Wieczorek J Andrich PH Kraus JT Epplen, Hum Genet 2007 122 175 82 10.1007/s00439-007-0393-4 17569088
9. Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds. JM Andresen J Gayan SS Cherny D Brocklebank G Alkorta-Aranburu EA Addis LR Cardon DE Housman NS Wexler, J Med Genet 2007 44 44 50 10.1136/jmg.2006.045153 17018562
10. ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease. L Arning D Monté W Hansen S Wieczorek P Jagiello DA Akkad J Andrich PH Kraus C Saft JT Epplen, J Mol Med 2008 86 485 490 10.1007/s00109-007-0299-6 18327563
11. Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease. S Metzger J Rong HP Nguyen A Cape J Tomiuk AS Soehn P Propping Y Freudenberg-Hua J Freudenberg L Tong SH Li XJ Li O Riess, Hum Mol Genet 2008 17 1137 1146 10.1093/hmg/ddn003 18192679
12. A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. JL Li MR Hayden EW Almqvist RR Brinkman A Durr C Dode PJ Morrison O Suchowersky CA Ross RL Margolis, Am J Hum Genet 2003 73 682 687 12900792 10.1086/378133
13. Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study. JL Li MR Hayden SC Warby A Durr PJ Morrison M Nance CA Ross RL Margolis A Rosenblatt F Squitieri, BMC Med Genet 2006 7 71 16914060 10.1186/1471-2350-7-71
14. Genomewide linkage scan reveals novel loci modifying age of onset of Huntington's disease in the Venezuelan HD kindreds. J Gayán D Brocklebank JM Andresen G Alkorta-Aranburu US-Venezuela Collaborative Research Group M Zameel Cader SA Roberts SS Cherny NS Wexler LR Cardon DE Housman, Genet Epidemiol 2008 5 445 453 10.1002/gepi.20317
15. Mechanisms of neurodegeneration in Huntington's disease. JM Gil AC Rego, Eur J Neurosci 2008 27 2803 2820 10.1111/j.1460-9568.2008.06310.x 18588526
16. Peroxisome proliferatoractivated receptor-g coactivator 1a (PGC-1a): transcriptional coactivator and metabolic regulator. P Puigserver BM Spiegelman, Endocr Rev 2003 24 78 90 10.1210/er.2002-0012 12588810
17. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. L Cui H Jeong F Borovecki CN Parkhurst N Tanese D Krainc, Cell 2006 127 59 69 10.1016/j.cell.2006.09.015 17018277
18. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. J St-Pierre S Drori M Uldry JM Silvaggi J Rhee S Jäger C Handschin K Zheng J Lin W Yang DK Simon R Bachoo BM Spiegelman, Cell 2006 127 397 408 10.1016/j.cell.2006.09.024 17055439
19. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. P Weydt VV Pineda AE Torrence RT Libby TF Satterfield ER Lazarowski ML Gilbert GJ Morton TK Bammler AD Strand L Cui RP Beyer CN Easley AC Smith D Krainc S Luquet IR Sweet MW Schwartz AR La Spada, Cell Metab 2006 4 349 62 10.1016/j.cmet.2006.10. 004 17055784
20. Associations of PPARGC1A haplotypes with plaque score but not with intima-media thickness of carotid arteries in middle-aged subjects. B Iglseder H Oberkofler TK Felder K Klein B Paulweber F Krempler DA Tregouet W Patsch, Stroke 2006 37 2260 2265 10.1161/01.STR.0000238584.57864.d4 16902166
21. Computer-assisted analysis of transcription control regions. Matinspector and other programs. T Werner, Methods Mol Biol 2000 132 337 349 10547845
22. The gene coding for PGC-1alpha modifies age at onset in Huntington's Disease. P Weydt S Soyal C Gellera S DiDonato C Weidinger H Oberkofler B Landwehrmeyer W Patsch, Molecular Neurodegeneration 2009 4 3 19133136 10.1186/1750-1326-4-3